Medicines Company buys Annovation after backing anesthesia startup
This article was originally published in Scrip
Executive Summary
The Medicines Company (MDCO) bought privately-held anesthesia drug developer Annovation BioPharma by acquiring the last 64% of outstanding shares that MDCO didn't own.